Patent details

EP1066314 Title: NOVEL EXENDIN AGONIST COMPOUNDS

Basic Information

Publication number:
EP1066314
PCT Application Number:
PCT/US/1998/024210
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP989578976
PCT Publication Number:
WO/1999/025727
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NOVEL EXENDIN AGONIST COMPOUNDS
French Title of Invention:
NOUVEAUX COMPOSES AGONISTES DE L'EXENDINE
German Title of Invention:
NEUARTIGE EXENDIN AGONISTEN
SPC Number:

Dates

Filing date:
13/11/1998
Grant date:
26/12/2007
EP Publication Date:
26/12/2007
PCT Publication Date:
27/05/1999
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/01/2001
EP B1 Publication Date:
26/12/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
13/11/2008
Expiration date:
13/11/2018
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/11/1998
 
 

Name:
AMYLIN PHARMACEUTICALS INC.
Address:
9360 Towne Centre Drive, San Diego, CA 92121, United States (US)

Inventor

1

Name:
PRICKETT Kathryn, S.
Address:
United States (US)

2

Name:
BEELEY Nigel, Robert, Arnold
Address:
United States (US)

Priority

Priority Number:
65442 P
Priority Date:
14/11/1997
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/16;
Filing date Document type Number of pages